Fitness to Practise Cases
This archive contains General Pharmaceutical Council (GPhC) Fitness to Practise (FtP) case summaries, detailing regulatory decisions affecting pharmacy professionals in the UK.
Each case provides insight into professional misconduct, errors, and ethical breaches that led to sanctions such as suspension, removal, or warnings. These summaries are valuable for:
- Pharmacists & Pharmacy Technicians – to understand common regulatory pitfalls.
- Employers & HR Teams – to learn about professional accountability and compliance.
- Pharmacy Students – to prepare for real-world ethical challenges in pharmacy practice.
Why it matters:
The decisions in these cases shape the legal and ethical landscape of pharmacy practice. Staying informed can help pharmacy professionals avoid similar mistakes and maintain high professional standards.
Use the form below to search for and filter cases that match your interests
Page 20 of 54
Warning Issued for Dishonest Removal of Amitriptyline by Pharmacist
Allegations The case revolves around a pharmacist who, on 12 August 2024, removed three boxes of 28 Amitriptyline 10mg tablets from the pharmacy shelf without obtaining a valid prescription, making payment, or securing permission from her employer. This conduct was identified during an internal investigation after the medication was discovered in the registrant’s vehicle. Initially, […]
29 October 2025
Clinical Pharmacist Warned for Falsifying Patient Records: A Cautionary Tale on Documentation Integrity
Allegations This case revolves around a clinical pharmacist employed by Coventry and Rugby GP Alliance (CRGPA) who was found to have created false entries in patient records. The conduct in question took place between December 2023 and January 2024, during which the registrant recorded details of patient interactions that had never occurred. Specifically, these entries […]
Pharmacist’s Suspension Ends After Sexual Harassment Misconduct and Intensive Remediation
Allegations This case centred on serious professional misconduct by the registrant, a pharmacist, while employed at Buchans Chemist in Birmingham. The allegations related to a series of inappropriate and sexually motivated behaviours towards a female colleague (“Colleague A”) during and after their shared shifts. These included sending an unsolicited message via WhatsApp stating, “Don’t sit […]
Warning Issued to GP Prescribing Pharmacist for Inadequate Assessments and Unsafe Prescribing Practices
Allegations The case revolves around a pharmacist and Independent Prescriber who was employed at a GP practice in Banbury. The registrant, operating in a patient-facing capacity, was responsible for diagnostic assessments, prescribing decisions, and medication reviews. Between 2022 and 2024, a series of concerning professional lapses led to regulatory scrutiny by the General Pharmaceutical Council […]
Warning Issued for Failing to Vet Online Prescribing Service: Lessons on Pharmacist Due Diligence
Allegations This case centers on the conduct of a pharmacist who, between June 2023 and July 2024, operated as both a director and, on occasion, the Responsible Pharmacist (RP) at a pharmacy dispensing medication for an online prescribing service. The core allegations involved failures in professional judgement, governance, and due diligence relating to this arrangement. […]
Pharmacist Warned for Unprofessional Conduct, Dispensing Errors, and Inappropriate Workplace Behaviour
Allegations This case centres around the conduct of a locum pharmacist practising in retail pharmacies in Bristol. The allegations spanned multiple incidents and included both clinical and interpersonal concerns. On 27 July 2024, the registrant failed to return a patient’s prescription to the NHS spine upon request, a procedural error that may have disrupted the […]
Pharmacist Suspended for Inadequate Prescribing Practices of Saxenda via Online Consultations
Allegations The registrant, a pharmacist and Superintendent Pharmacist at Burwash Pharmacy, faced a series of serious allegations relating to the unsafe prescribing of Saxenda, a prescription-only weight loss medication. Between 2019 and 2022, Saxenda was issued through online consultations with patients, primarily relying on self-reported questionnaires without robust clinical verification. Concerns were raised by healthcare […]
22 October 2025
Pharmacist Warned for Remotely Approving Prescriptions via WhatsApp While Pharmacy Operated Unsupervised
Allegations This case revolves around a registered pharmacist who served as the Responsible Pharmacist at Swindon Pharmacy on six specified dates in late 2022 and mid-2023. Despite being officially responsible, the registrant was not physically present at the pharmacy on any of those dates. Critically, while the pharmacy was operational without a pharmacist on-site, prescription […]
20 October 2025
Superintendent Pharmacist Warned Over Lapses in Online Pharmacy Governance and Controlled Drug Wholesale Export
Allegations This case revolves around serious allegations concerning the registrant’s conduct during her tenure as Superintendent Pharmacist (SI) at Dock Pharmacy in Tilbury, Essex, from February to June 2021. The core concern relates to the registrant’s failure to appropriately oversee and manage the risks associated with the pharmacy’s online operations. During this period, the pharmacy […]
19 October 2025
Suspended Sentence for NI Superintendent Pharmacist Following Prolonged Unlawful Supply of Controlled Drugs
Allegations This case involves serious and sustained misconduct by the registrant, a superintendent pharmacist and director of Castlereagh Pharmacy Ltd, who was convicted of multiple criminal offences and found to have repeatedly breached professional standards and legal obligations. Between 2017 and 2020, the registrant unlawfully supplied significant quantities of prescription-only and controlled drugs, including Co-codamol, […]
14 October 2025